Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;32(2):951-960.
doi: 10.3758/s13423-024-02601-5. Epub 2024 Oct 24.

Increasing transparency of computer-aided detection impairs decision-making in visual search

Affiliations

Increasing transparency of computer-aided detection impairs decision-making in visual search

Melina A Kunar et al. Psychon Bull Rev. 2025 Apr.

Abstract

Recent developments in artificial intelligence (AI) have led to changes in healthcare. Government and regulatory bodies have advocated the need for transparency in AI systems with recommendations to provide users with more details about AI accuracy and how AI systems work. However, increased transparency could lead to negative outcomes if humans become overreliant on the technology. This study investigated how changes in AI transparency affected human decision-making in a medical-screening visual search task. Transparency was manipulated by either giving or withholding knowledge about the accuracy of an 'AI system'. We tested performance in seven simulated lab mammography tasks, in which observers searched for a cancer which could be correctly or incorrectly flagged by computer-aided detection (CAD) 'AI prompts'. Across tasks, the CAD systems varied in accuracy. In the 'transparent' condition, participants were told the accuracy of the CAD system, in the 'not transparent' condition, they were not. The results showed that increasing CAD transparency impaired task performance, producing an increase in false alarms, decreased sensitivity, an increase in recall rate, and a decrease in positive predictive value. Along with increasing investment in AI, this research shows that it is important to investigate how transparency of AI systems affect human decision-making. Increased transparency may lead to overtrust in AI systems, which can impact clinical outcomes.

Keywords: Artificial intelligence; Computer-aided detection (CAD); Low prevalence; Overreliance; Transparency; Visual search.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of interest/Competing interests: The authors declare that they have no conflicts of interest/competing interests. Ethics approval: Ethical approval for all studies was granted by the Humanities and Social Sciences Research Ethics Committee at the University of Warwick. Consent to participate: All participants provided informed consent prior to completing the experiment. Consent for publication: Not applicable. Open practices statement: The data and materials for all experiments are available online ( https://osf.io/zrafu/ ). None of the experiments were preregistered.

Figures

Fig. 1
Fig. 1
Examples of mammogram displays with correct CAD, incorrect CAD, and no CAD for cancer-present trials and incorrect CAD and no CAD (correct) for cancer-absent conditions
Fig. 2
Fig. 2
Mean values across conditions. Note. Error bars represent the standard error

Similar articles

References

    1. Alexander, A., Jiang, A., Ferreira, C., & Zurkiya, D. (2020). An intelligent future for medical imaging: A market outlook on artificial intelligence for medical imaging. Journal of the American College of Radiology,17(1), 165–170. - PubMed
    1. Allen, B., Agarwal, S., Coombs, L., Wald, C., & Dreyer, K. (2021). 2020 ACR Data Science Institute artificial intelligence survey. Journal of the American College of Radiology,18(8), 1153–1159. - PubMed
    1. Aro, A. R. (2000). False-positive findings in mammography screening induces short-term distress—Breast cancer-specific concern prevails longer. European Journal of Cancer,36, 1089–1097. - PubMed
    1. Askin, S., Burkhalter, D., Calado, G., & El Dakrouni, S. (2023). Artificial intelligence applied to clinical trials: Opportunities and challenges. Health and Technology,13, 203–213. - PMC - PubMed
    1. Benjamens, S., Dhunnoo, P., & Meskó, B. (2020). The state of artificial intelligence-based FDA-approved medical devices and algorithms: An online database. NPJ Digital Medicine,3(1), 118. - PMC - PubMed

LinkOut - more resources